Cargando…

The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease

In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Awahara, Chiyuki, Oku, Daiki, Furuta, Saki, Kobayashi, Kazuya, Teruya, Kenta, Akaji, Kenichi, Hattori, Yasunao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911550/
https://www.ncbi.nlm.nih.gov/pubmed/35268749
http://dx.doi.org/10.3390/molecules27051646
_version_ 1784666841155633152
author Awahara, Chiyuki
Oku, Daiki
Furuta, Saki
Kobayashi, Kazuya
Teruya, Kenta
Akaji, Kenichi
Hattori, Yasunao
author_facet Awahara, Chiyuki
Oku, Daiki
Furuta, Saki
Kobayashi, Kazuya
Teruya, Kenta
Akaji, Kenichi
Hattori, Yasunao
author_sort Awahara, Chiyuki
collection PubMed
description In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors.
format Online
Article
Text
id pubmed-8911550
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89115502022-03-11 The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease Awahara, Chiyuki Oku, Daiki Furuta, Saki Kobayashi, Kazuya Teruya, Kenta Akaji, Kenichi Hattori, Yasunao Molecules Article In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors. MDPI 2022-03-02 /pmc/articles/PMC8911550/ /pubmed/35268749 http://dx.doi.org/10.3390/molecules27051646 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Awahara, Chiyuki
Oku, Daiki
Furuta, Saki
Kobayashi, Kazuya
Teruya, Kenta
Akaji, Kenichi
Hattori, Yasunao
The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_full The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_fullStr The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_full_unstemmed The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_short The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_sort effects of side-chain configurations of a retro–inverso-type inhibitor on the human t-cell leukemia virus (htlv)-1 protease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911550/
https://www.ncbi.nlm.nih.gov/pubmed/35268749
http://dx.doi.org/10.3390/molecules27051646
work_keys_str_mv AT awaharachiyuki theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT okudaiki theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT furutasaki theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kobayashikazuya theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT teruyakenta theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT akajikenichi theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT hattoriyasunao theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT awaharachiyuki effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT okudaiki effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT furutasaki effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kobayashikazuya effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT teruyakenta effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT akajikenichi effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT hattoriyasunao effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease